This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Weekly Jobless Data Worsens, Q2 Earnings Mixed, Futures Dip
by Zacks Equity Research
Weekly jobless claims data surpasses one million mark again for the week ended Aug 15.
Estee Lauder's (EL) Q4 Loss Wider Than Estimates, Sales Down
by Zacks Equity Research
Estee Lauder's (EL) fourth-quarter fiscal 2020 sales decline due to coronavirus-induced retail store closures. The company launches a two-year plan called Post-COVID Business Acceleration Program.
Estee Lauder (EL) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of -178.95% and -1.32%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Why Earnings Season Could Be Great for Estee Lauder (EL)
by Zacks Equity Research
Estee Lauder (EL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
The 5 Hottest Earnings Charts This Week
by Tracey Ryniec
Who says only the FAANG stocks are breaking out?
Here's How Estee Lauder (EL) Looks Ahead of Q4 Earnings
by Zacks Equity Research
Adverse impacts of coronavirus-induced temporary store closures and sluggishness in travel retail are likely to get reflected in Estee Lauder's (EL) fourth-quarter fiscal 2020 results.
Analysts Estimate Estee Lauder (EL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NUS vs. EL: Which Stock Is the Better Value Option?
by Zacks Equity Research
NUS vs. EL: Which Stock Is the Better Value Option?
Here's How Post Holdings (POST) Looks Ahead of Q3 Earnings
by Zacks Equity Research
Impacts of higher costs as well as lower demand in foodservice business are likely to get reflected in Post Holdings' (POST) third-quarter fiscal 2020 performance.
What's in the Cards for Medifast (MED) This Earnings Season?
by Zacks Equity Research
Strength in OPTAVIA brand is likely to get reflected in Medifast's (MED) second-quarter 2020 performance. However, rising SG&A expenses is a concern.
Things to Know Before Celsius Holdings (CELH) Q2 Earnings
by Zacks Equity Research
Celsius Holdings' (CELH) second-quarter results are likely to have benefited from strong brands and its solid network of retailers and distributors. However, rising costs are concerning.
Is Colgate (CL) Poised to Beat Earnings Estimates in Q2?
by Zacks Equity Research
Colgate's (CL) second-quarter 2020 sales are likely to have benefited from investment in brands, favorable pricing strategy, innovative product launches and enhancement of e-commerce capabilities.
Why Estee Lauder (EL) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Estee Lauder (EL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Zacks Analyst Blog Highlights: Netflix, AstraZeneca, Union Pacific, NextEra Energy and Estee Lauder
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Netflix, AstraZeneca, Union Pacific, NextEra Energy and Estee Lauder
Top Analyst Reports for Netflix, AstraZeneca & Union Pacific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Netflix (NFLX), AstraZeneca (AZN) and Union Pacific (UNP).
Estee Lauder's (EL) Robust E-commerce Business Bodes Well
by Zacks Equity Research
Estee Lauder (EL) is benefiting from impressive cost-saving efforts amid the pandemic. The company's robust digital sales are cushioning from the coronavirus outbreak-led store closures.
Coty (COTY) to Buy Stake in Kim Kardashian's Beauty Business
by Zacks Equity Research
Coty (COTY) announced its decision to buy 20% stake in Kim Kardashian's beauty business for $200 million.
Procter & Gamble Displays Strength on Demand for Products
by Zacks Equity Research
Procter & Gamble (PG) is benefiting from increased demand for hand soaps, detergents and surface-cleaning products during the pandemic.
3 Factors That Make Helen of Troy (HELE) an Attractive Pick
by Zacks Equity Research
Strength in Helen of Troy's (HELE) Leadership Brands is driving growth. Moreover, the company's focus on enhancing online business is yielding.
Estee Lauder Benefits From Online Sales Amid Store Closures
by Zacks Equity Research
Estee Lauder (EL) is gaining from solid online sales amid coronavirus-led store closures. Also, the company's efficient cost-saving efforts are yielding.
Ulta Beauty Teams With Credo to Offer Clean Beauty Items
by Zacks Equity Research
Ulta Beauty's (ULTA) partnership with Credo Beauty to offer clean beauty products is likely to strengthen its footing in the evolving clean beauty space.
HELE or EL: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
HELE vs. EL: Which Stock Is the Better Value Option?
Why Is Estee Lauder (EL) Up 11.9% Since Last Earnings Report?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Consumer Staple Stocks Set to Beat Earnings Despite Coronavirus
by Vrishali Bagree
Several players in the Consumer Staples sector have been benefiting from rising demand owing to the coronavirus-led pantry loading. We have selected five stocks with an earnings beat potential.
Cosmetics Industry Outlook Prospects Dimmed by Coronavirus Woes
by Vrishali Bagree
The Cosmetics space appears to be under pressure, thanks to coronavirus-led concerns like major travel restrictions, delay in product launches and temporary store closures in some regions.